Spire Wealth Management’s United Therapeutics UTHR Stock Holding History

Spire Wealth Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$32K	Buy	+59	New	+$33.2K	﹤0.01%	1297
2026 Q1	–	Sell	-309	Closed	-$151K	–	2408
2025 Q4	$151K	Buy	+309	New	+$144K	0.01%	875
2025 Q2	–	Sell	-5	Closed	-$1.54K	–	2574
2025 Q1	$1.54K	Buy	5 +2	+67%	+$685	﹤0.01%	2320
2024 Q4	$1.06K	Buy	+3	New	+$1.1K	﹤0.01%	2361
2022 Q1	–	Sell	-425	Closed	-$92K	–	2880
2021 Q4	$92K	Buy	+425	New	+$83.4K	﹤0.01%	1436
2021 Q2	–	Sell	-752	Closed	-$129K	–	2966
2021 Q1	$129K	Buy	+752	New	+$125K	﹤0.01%	1277

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

Spire Wealth Management's UTHR Position: Q2 2026 in Review

Spire Wealth Management opened a new position in United Therapeutics (UTHR) in Q2 2026: 59 shares worth $32K. The stake represents ﹤0.01% of the portfolio and ranks #1297 among its holdings. This is a return to the name: Spire Wealth Management previously reported a position in UTHR as recently as Q4 2025.

Spire Wealth Management first reported a position in UTHR in Q1 2021 and has held it in 6 quarters since. The position peaked at $151K in Q4 2025. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Spire Wealth Management held 59 shares of United Therapeutics worth $32K as of Q2 2026.
United Therapeutics was a new Spire Wealth Management position in Q2 2026.
United Therapeutics made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1297 holding.
Spire Wealth Management first reported a position in United Therapeutics in Q1 2021 and has held it in 6 quarters since.
Spire Wealth Management's United Therapeutics position peaked at $151K in Q4 2025.
880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.